US 11407822
Treatment of fibrodysplasia ossificans progressiva
granted A61KA61K2039/505A61K38/179
Quick answer
US patent 11407822 (Treatment of fibrodysplasia ossificans progressiva) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Aug 09 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 04 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K2039/505, A61K38/179, A61K39/39533, A61K39/3955